A High Creatine Kinase Concentration Might Be a Sign of McArdle Disease in Patient With Type 1 Diabetes

dc.contributor.authorUgur, Kader
dc.contributor.authorAydogan, Yakup
dc.contributor.authorAkgun, Abdurrahman
dc.contributor.authorAydin, Suleyman
dc.date.accessioned2026-08-12T17:00:41Z
dc.date.issued2019
dc.departmentFırat Üniversitesi
dc.description.abstractType 1 diabetes (the pancreas producing little or no insulin) is usually diagnosed in children and young adults and was previously known as juvenile diabetes. McArdle disease is a common metabolic defect caused by an inherited deficit of myophosphorylase. These 2 diseases might have some clinical heterogeneity. Here, we discuss a McArdle disease case where insulin-dependent diabetes overshadows its early diagnosis. In this case, an insulin-dependent 22-year-old female patient with diabetes mellitus had been on diabetes treatment for 15 years. Although her blood glucose was regulated, her anamnesis showed that muscle weakness, fatigue, cramps or myalgia never healed. Based on her anamnesis, the patient was asked to take a nonischemic forearm exercise test, which revealed significant elevation in levels of creatine kinase (5968-7906 U/L), but no increase was found in lactate concentration, but a slight increase in ammonia concentration (not statistically significant) at the end of the test made us consider McArdle disease. A genetic test was done to confirm this possibility. A homozygous c.2128_2130delTTC/p.Phe710del mutation was detected in the examination of exons of the PYGM gene, which confirmed the diagnosis of McArdle disease in our patient. According to the data, this is a rare case of McArdle disease with type 1 diabetes. During treatment for diabetes, if the above-mentioned symptoms are present in a patient, and especially if the patient's creatine kinase concentration is high, muscle diseases should be suspected. Therefore, we suggest that this case report will provide new insight to clinicians on metabolic defects in this disease and increase the patient comfort. In such cases, an early diagnosis should reduce health costs.
dc.identifier.doi10.1177/1178626419861407
dc.identifier.issn1178-6264
dc.identifier.orcid0000-0003-4028-2041
dc.identifier.pmid31320798
dc.identifier.urihttps://doi.org/10.1177/1178626419861407
dc.identifier.urihttps://hdl.handle.net/11508/47317
dc.identifier.volume12
dc.identifier.wosWOS:000490174000001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Ltd
dc.relation.ispartofBiochemistry Insights
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectMcArdle disease
dc.subjectmyophosphorylase
dc.subjectdiabetes mellitus
dc.subjectmyalgia
dc.titleA High Creatine Kinase Concentration Might Be a Sign of McArdle Disease in Patient With Type 1 Diabetes
dc.typeArticle

Dosyalar